nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS2—thyroid cancer	0.47	1	CbGaD
Meclofenamic acid—AKR1C3—Doxorubicin—thyroid cancer	0.339	1	CbGbCtD
Meclofenamic acid—ALOX5—Synthesis of Lipoxins (LX)—HPGD—thyroid cancer	0.0161	0.159	CbGpPWpGaD
Meclofenamic acid—ALOX5—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0108	0.108	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00812	0.0806	CbGpPWpGaD
Meclofenamic acid—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0047	0.0467	CbGpPWpGaD
Meclofenamic acid—Visual acuity reduced—Vandetanib—thyroid cancer	0.00445	0.058	CcSEcCtD
Meclofenamic acid—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00373	0.0371	CbGpPWpGaD
Meclofenamic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00353	0.0351	CbGpPWpGaD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00294	0.0292	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00293	0.0291	CbGpPWpGaD
Meclofenamic acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00281	0.0279	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—RXRA—thyroid cancer	0.00278	0.0276	CbGpPWpGaD
Meclofenamic acid—Acetylsalicylic acid—TP53—thyroid cancer	0.00259	0.436	CrCbGaD
Meclofenamic acid—Colitis—Vandetanib—thyroid cancer	0.00254	0.0331	CcSEcCtD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00192	0.0191	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—RXRA—thyroid cancer	0.00191	0.0189	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of bile acids and bile salts—RXRA—thyroid cancer	0.00173	0.0172	CbGpPWpGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00167	0.0166	CbGpPWpGaD
Meclofenamic acid—Neutropenia—Vandetanib—thyroid cancer	0.00155	0.0202	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Epirubicin—thyroid cancer	0.00153	0.0199	CcSEcCtD
Meclofenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00152	0.0151	CbGpPWpGaD
Meclofenamic acid—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00147	0.0191	CcSEcCtD
Meclofenamic acid—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.00146	0.0145	CbGpPWpGaD
Meclofenamic acid—Renal failure—Vandetanib—thyroid cancer	0.00145	0.019	CcSEcCtD
Meclofenamic acid—Stomatitis—Vandetanib—thyroid cancer	0.00144	0.0188	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Vandetanib—thyroid cancer	0.00144	0.0187	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Doxorubicin—thyroid cancer	0.00141	0.0184	CcSEcCtD
Meclofenamic acid—AKR1C3—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00138	0.0137	CbGpPWpGaD
Meclofenamic acid—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00137	0.0179	CcSEcCtD
Meclofenamic acid—Haemoglobin—Vandetanib—thyroid cancer	0.00134	0.0174	CcSEcCtD
Meclofenamic acid—AKR1C3—Metapathway biotransformation—CHST14—thyroid cancer	0.00134	0.0133	CbGpPWpGaD
Meclofenamic acid—Haemorrhage—Vandetanib—thyroid cancer	0.00133	0.0173	CcSEcCtD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00128	0.0127	CbGpPWpGaD
Meclofenamic acid—Erythema multiforme—Vandetanib—thyroid cancer	0.00126	0.0164	CcSEcCtD
Meclofenamic acid—Blindness—Epirubicin—thyroid cancer	0.00119	0.0155	CcSEcCtD
Meclofenamic acid—Alopecia—Vandetanib—thyroid cancer	0.00117	0.0153	CcSEcCtD
Meclofenamic acid—Blindness—Doxorubicin—thyroid cancer	0.0011	0.0144	CcSEcCtD
Meclofenamic acid—Vision blurred—Vandetanib—thyroid cancer	0.00109	0.0142	CcSEcCtD
Meclofenamic acid—Neutropenia—Sorafenib—thyroid cancer	0.00105	0.0136	CcSEcCtD
Meclofenamic acid—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00101	0.0101	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000991	0.00984	CbGpPWpGaD
Meclofenamic acid—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00099	0.0129	CcSEcCtD
Meclofenamic acid—Renal failure—Sorafenib—thyroid cancer	0.000981	0.0128	CcSEcCtD
Meclofenamic acid—Stomatitis—Sorafenib—thyroid cancer	0.000973	0.0127	CcSEcCtD
Meclofenamic acid—ALOX5—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.00095	0.00943	CbGpPWpGaD
Meclofenamic acid—Oedema—Vandetanib—thyroid cancer	0.000944	0.0123	CcSEcCtD
Meclofenamic acid—Haemoglobin—Sorafenib—thyroid cancer	0.000901	0.0117	CcSEcCtD
Meclofenamic acid—Haemorrhage—Sorafenib—thyroid cancer	0.000896	0.0117	CcSEcCtD
Meclofenamic acid—KCNQ3—head—thyroid cancer	0.000863	0.116	CbGeAlD
Meclofenamic acid—Lumiracoxib—PTGS2—thyroid cancer	0.000858	0.144	CrCbGaD
Meclofenamic acid—Insomnia—Vandetanib—thyroid cancer	0.000854	0.0111	CcSEcCtD
Meclofenamic acid—Paraesthesia—Vandetanib—thyroid cancer	0.000848	0.011	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Sorafenib—thyroid cancer	0.000847	0.011	CcSEcCtD
Meclofenamic acid—Tinnitus—Sorafenib—thyroid cancer	0.000836	0.0109	CcSEcCtD
Meclofenamic acid—Decreased appetite—Vandetanib—thyroid cancer	0.000821	0.0107	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000815	0.0106	CcSEcCtD
Meclofenamic acid—Fatigue—Vandetanib—thyroid cancer	0.000814	0.0106	CcSEcCtD
Meclofenamic acid—Constipation—Vandetanib—thyroid cancer	0.000807	0.0105	CcSEcCtD
Meclofenamic acid—KCNQ2—head—thyroid cancer	0.000795	0.107	CbGeAlD
Meclofenamic acid—Alopecia—Sorafenib—thyroid cancer	0.000792	0.0103	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000772	0.0101	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000751	0.00978	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vandetanib—thyroid cancer	0.000746	0.00972	CcSEcCtD
Meclofenamic acid—AKR1C3—trachea—thyroid cancer	0.000724	0.0973	CbGeAlD
Meclofenamic acid—Nocturia—Epirubicin—thyroid cancer	0.000711	0.00927	CcSEcCtD
Meclofenamic acid—Leukopenia—Sorafenib—thyroid cancer	0.000698	0.0091	CcSEcCtD
Meclofenamic acid—Ulcer—Epirubicin—thyroid cancer	0.000697	0.00909	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000695	0.00905	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—thyroid cancer	0.000678	0.114	CrCbGaD
Meclofenamic acid—Asthenia—Vandetanib—thyroid cancer	0.000677	0.00883	CcSEcCtD
Meclofenamic acid—Pruritus—Vandetanib—thyroid cancer	0.000668	0.0087	CcSEcCtD
Meclofenamic acid—Nocturia—Doxorubicin—thyroid cancer	0.000658	0.00857	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vandetanib—thyroid cancer	0.000646	0.00842	CcSEcCtD
Meclofenamic acid—Ulcer—Doxorubicin—thyroid cancer	0.000645	0.00841	CcSEcCtD
Meclofenamic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.000634	0.0063	CbGpPWpGaD
Meclofenamic acid—Colitis—Epirubicin—thyroid cancer	0.000633	0.00825	CcSEcCtD
Meclofenamic acid—SLCO1C1—thyroid gland—thyroid cancer	0.000623	0.0838	CbGeAlD
Meclofenamic acid—Anorexia—Sorafenib—thyroid cancer	0.000607	0.00791	CcSEcCtD
Meclofenamic acid—Vomiting—Vandetanib—thyroid cancer	0.0006	0.00782	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—thyroid cancer	0.000586	0.00764	CcSEcCtD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000579	0.00575	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000579	0.00575	CbGpPWpGaD
Meclofenamic acid—AKR1C3—thyroid gland—thyroid cancer	0.000572	0.077	CbGeAlD
Meclofenamic acid—Nausea—Vandetanib—thyroid cancer	0.000561	0.00731	CcSEcCtD
Meclofenamic acid—Decreased appetite—Sorafenib—thyroid cancer	0.000554	0.00721	CcSEcCtD
Meclofenamic acid—SLCO1C1—head—thyroid cancer	0.000553	0.0743	CbGeAlD
Meclofenamic acid—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00055	0.00716	CcSEcCtD
Meclofenamic acid—Fatigue—Sorafenib—thyroid cancer	0.000549	0.00715	CcSEcCtD
Meclofenamic acid—Constipation—Sorafenib—thyroid cancer	0.000545	0.0071	CcSEcCtD
Meclofenamic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000533	0.00529	CbGpPWpGaD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000528	0.00524	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000526	0.00522	CbGpPWpGaD
Meclofenamic acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000521	0.00679	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—thyroid cancer	0.00052	0.0875	CrCbGaD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000507	0.00661	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—thyroid cancer	0.000506	0.0852	CrCbGaD
Meclofenamic acid—Urticaria—Sorafenib—thyroid cancer	0.000506	0.00659	CcSEcCtD
Meclofenamic acid—ALOX5—thyroid gland—thyroid cancer	0.000505	0.0678	CbGeAlD
Meclofenamic acid—Abdominal pain—Sorafenib—thyroid cancer	0.000503	0.00656	CcSEcCtD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000497	0.00493	CbGpPWpGaD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00047	0.00612	CcSEcCtD
Meclofenamic acid—Asthenia—Sorafenib—thyroid cancer	0.000457	0.00595	CcSEcCtD
Meclofenamic acid—Pruritus—Sorafenib—thyroid cancer	0.000451	0.00587	CcSEcCtD
Meclofenamic acid—ALOX5—head—thyroid cancer	0.000448	0.0602	CbGeAlD
Meclofenamic acid—Diarrhoea—Sorafenib—thyroid cancer	0.000436	0.00568	CcSEcCtD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000434	0.00431	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000421	0.00418	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000419	0.00416	CbGpPWpGaD
Meclofenamic acid—Salicylic acid—PTGS2—thyroid cancer	0.000417	0.0702	CrCbGaD
Meclofenamic acid—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000412	0.00409	CbGpPWpGaD
Meclofenamic acid—Eosinophilia—Epirubicin—thyroid cancer	0.00041	0.00534	CcSEcCtD
Meclofenamic acid—Vomiting—Sorafenib—thyroid cancer	0.000405	0.00528	CcSEcCtD
Meclofenamic acid—SLCO1C1—lymph node—thyroid cancer	0.000387	0.052	CbGeAlD
Meclofenamic acid—Neutropenia—Epirubicin—thyroid cancer	0.000387	0.00504	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—thyroid cancer	0.000379	0.00494	CcSEcCtD
Meclofenamic acid—Nausea—Sorafenib—thyroid cancer	0.000378	0.00493	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—thyroid cancer	0.000373	0.0628	CrCbGaD
Meclofenamic acid—KCNQ2—Axon guidance—CDK1—thyroid cancer	0.000369	0.00367	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—CDK1—thyroid cancer	0.000369	0.00367	CbGpPWpGaD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000366	0.00477	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—thyroid cancer	0.000363	0.00473	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—thyroid cancer	0.00036	0.00469	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—thyroid cancer	0.000359	0.00467	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—thyroid cancer	0.000358	0.00467	CcSEcCtD
Meclofenamic acid—AKR1C3—lymph node—thyroid cancer	0.000356	0.0478	CbGeAlD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000345	0.00342	CbGpPWpGaD
Meclofenamic acid—Agranulocytosis—Epirubicin—thyroid cancer	0.000344	0.00449	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000338	0.00441	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000336	0.00334	CbGpPWpGaD
Meclofenamic acid—Renal failure—Doxorubicin—thyroid cancer	0.000336	0.00437	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—thyroid cancer	0.000333	0.00434	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—thyroid cancer	0.000333	0.00434	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—thyroid cancer	0.000332	0.00432	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—thyroid cancer	0.000331	0.00432	CcSEcCtD
Meclofenamic acid—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000323	0.00321	CbGpPWpGaD
Meclofenamic acid—Agranulocytosis—Doxorubicin—thyroid cancer	0.000319	0.00415	CcSEcCtD
Meclofenamic acid—ALOX5—lymph node—thyroid cancer	0.000313	0.0421	CbGeAlD
Meclofenamic acid—Erythema multiforme—Epirubicin—thyroid cancer	0.000313	0.00408	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—thyroid cancer	0.000309	0.00402	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—thyroid cancer	0.000308	0.00401	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—thyroid cancer	0.000306	0.00399	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000294	0.00292	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000294	0.00292	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TRIM24—thyroid cancer	0.000294	0.00292	CbGpPWpGaD
Meclofenamic acid—Alopecia—Epirubicin—thyroid cancer	0.000293	0.00381	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism—MINPP1—thyroid cancer	0.000291	0.00289	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.00029	0.00288	CbGpPWpGaD
Meclofenamic acid—Erythema multiforme—Doxorubicin—thyroid cancer	0.00029	0.00378	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism—MINPP1—thyroid cancer	0.00029	0.00288	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00029	0.00288	CbGpPWpGaD
Meclofenamic acid—Tinnitus—Doxorubicin—thyroid cancer	0.000286	0.00372	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—CHST14—thyroid cancer	0.000276	0.00275	CbGpPWpGaD
Meclofenamic acid—Vision blurred—Epirubicin—thyroid cancer	0.000272	0.00354	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—thyroid cancer	0.000271	0.00353	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—thyroid cancer	0.000268	0.00349	CcSEcCtD
Meclofenamic acid—KCNQ2—Developmental Biology—CDK1—thyroid cancer	0.000263	0.00262	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—CDK1—thyroid cancer	0.000263	0.00262	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TRIM33—thyroid cancer	0.000262	0.0026	CbGpPWpGaD
Meclofenamic acid—Malaise—Epirubicin—thyroid cancer	0.00026	0.00339	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—thyroid cancer	0.000258	0.00336	CcSEcCtD
Meclofenamic acid—PTGS1—trachea—thyroid cancer	0.000256	0.0344	CbGeAlD
Meclofenamic acid—Palpitations—Epirubicin—thyroid cancer	0.000255	0.00332	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—thyroid cancer	0.000251	0.00328	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000248	0.00323	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism—NDUFA13—thyroid cancer	0.000247	0.00246	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NDUFA13—thyroid cancer	0.000246	0.00245	CbGpPWpGaD
Meclofenamic acid—PTGS2—trachea—thyroid cancer	0.000245	0.0329	CbGeAlD
Meclofenamic acid—KCNQ3—Developmental Biology—RXRA—thyroid cancer	0.000245	0.00243	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—RXRA—thyroid cancer	0.000245	0.00243	CbGpPWpGaD
Meclofenamic acid—Discomfort—Epirubicin—thyroid cancer	0.000243	0.00316	CcSEcCtD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000242	0.00241	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000242	0.00241	CbGpPWpGaD
Meclofenamic acid—Malaise—Doxorubicin—thyroid cancer	0.000241	0.00314	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—thyroid cancer	0.000239	0.00311	CcSEcCtD
Meclofenamic acid—KCNQ2—Neuronal System—BRAF—thyroid cancer	0.000238	0.00236	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—BRAF—thyroid cancer	0.000238	0.00236	CbGpPWpGaD
Meclofenamic acid—Palpitations—Doxorubicin—thyroid cancer	0.000236	0.00307	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—thyroid cancer	0.000235	0.00307	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism—CHST14—thyroid cancer	0.000232	0.00231	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CHST14—thyroid cancer	0.000232	0.0023	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000231	0.0023	CbGpPWpGaD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000229	0.00227	CbGpPWpGaD
Meclofenamic acid—Discomfort—Doxorubicin—thyroid cancer	0.000224	0.00292	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—thyroid cancer	0.000224	0.00292	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00022	0.00219	CbGpPWpGaD
Meclofenamic acid—Oedema—Doxorubicin—thyroid cancer	0.000218	0.00284	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—thyroid cancer	0.000213	0.00277	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—thyroid cancer	0.000211	0.00275	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—thyroid cancer	0.000208	0.0027	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—thyroid cancer	0.000205	0.00267	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000203	0.00265	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—thyroid cancer	0.000203	0.00264	CcSEcCtD
Meclofenamic acid—PTGS1—thyroid gland—thyroid cancer	0.000203	0.0272	CbGeAlD
Meclofenamic acid—Constipation—Epirubicin—thyroid cancer	0.000201	0.00262	CcSEcCtD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000198	0.00197	CbGpPWpGaD
Meclofenamic acid—Insomnia—Doxorubicin—thyroid cancer	0.000197	0.00257	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—thyroid cancer	0.000196	0.00255	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—thyroid cancer	0.000194	0.00253	CcSEcCtD
Meclofenamic acid—AKR1C3—Signaling Pathways—CALCB—thyroid cancer	0.000194	0.00192	CbGpPWpGaD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000192	0.00251	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—thyroid cancer	0.000189	0.00247	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000188	0.00245	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—thyroid cancer	0.000188	0.00245	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism—HPGD—thyroid cancer	0.000187	0.00186	CbGpPWpGaD
Meclofenamic acid—Urticaria—Epirubicin—thyroid cancer	0.000187	0.00244	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism—HPGD—thyroid cancer	0.000187	0.00185	CbGpPWpGaD
Meclofenamic acid—Constipation—Doxorubicin—thyroid cancer	0.000186	0.00243	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—thyroid cancer	0.000186	0.00242	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000185	0.00184	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TRIM33—thyroid cancer	0.000184	0.00182	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000182	0.00181	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000181	0.0018	CbGpPWpGaD
Meclofenamic acid—PTGS1—head—thyroid cancer	0.00018	0.0242	CbGeAlD
Meclofenamic acid—Feeling abnormal—Doxorubicin—thyroid cancer	0.000179	0.00234	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000178	0.00232	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—TCF7L1—thyroid cancer	0.000175	0.00174	CbGpPWpGaD
Meclofenamic acid—Urticaria—Doxorubicin—thyroid cancer	0.000173	0.00225	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—thyroid cancer	0.000172	0.00224	CcSEcCtD
Meclofenamic acid—PTGS2—head—thyroid cancer	0.000172	0.0231	CbGeAlD
Meclofenamic acid—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000172	0.0017	CbGpPWpGaD
Meclofenamic acid—Asthenia—Epirubicin—thyroid cancer	0.000169	0.0022	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—thyroid cancer	0.000166	0.00217	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—thyroid cancer	0.000161	0.0021	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—thyroid cancer	0.000156	0.00204	CcSEcCtD
Meclofenamic acid—KCNQ2—Developmental Biology—PPARG—thyroid cancer	0.000154	0.00153	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—PPARG—thyroid cancer	0.000154	0.00153	CbGpPWpGaD
Meclofenamic acid—Pruritus—Doxorubicin—thyroid cancer	0.000154	0.00201	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000152	0.00151	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000151	0.0015	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000151	0.0015	CbGpPWpGaD
Meclofenamic acid—Vomiting—Epirubicin—thyroid cancer	0.00015	0.00195	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—thyroid cancer	0.000149	0.00194	CcSEcCtD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000146	0.00145	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000145	0.00144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000144	0.00143	CbGpPWpGaD
Meclofenamic acid—Nausea—Epirubicin—thyroid cancer	0.00014	0.00182	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—thyroid cancer	0.000138	0.0018	CcSEcCtD
Meclofenamic acid—KCNQ3—Axon guidance—NRAS—thyroid cancer	0.000132	0.00132	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—NRAS—thyroid cancer	0.000132	0.00132	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00013	0.00129	CbGpPWpGaD
Meclofenamic acid—Nausea—Doxorubicin—thyroid cancer	0.000129	0.00169	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—TPR—thyroid cancer	0.000128	0.00127	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000126	0.00125	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PRKAR1A—thyroid cancer	0.000126	0.00125	CbGpPWpGaD
Meclofenamic acid—PTGS1—lymph node—thyroid cancer	0.000126	0.0169	CbGeAlD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000125	0.00124	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000123	0.00122	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000123	0.00122	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TCF7L1—thyroid cancer	0.000122	0.00122	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000121	0.0012	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MEN1—thyroid cancer	0.00012	0.0012	CbGpPWpGaD
Meclofenamic acid—PTGS2—lymph node—thyroid cancer	0.00012	0.0162	CbGeAlD
Meclofenamic acid—KCNQ2—Axon guidance—KRAS—thyroid cancer	0.000114	0.00113	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—KRAS—thyroid cancer	0.000114	0.00113	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000111	0.0011	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—HRAS—thyroid cancer	0.000109	0.00108	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—HRAS—thyroid cancer	0.000109	0.00108	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000108	0.00108	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—TPR—thyroid cancer	0.000108	0.00107	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—TPR—thyroid cancer	0.000107	0.00106	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000107	0.00106	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PRKAR1A—thyroid cancer	0.000106	0.00105	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PRKAR1A—thyroid cancer	0.000105	0.00105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TRIM24—thyroid cancer	0.000102	0.00101	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CHST14—thyroid cancer	0.000101	0.001	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MINPP1—thyroid cancer	0.0001	0.000994	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—thyroid cancer	9.69e-05	0.000962	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—thyroid cancer	9.69e-05	0.000962	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.6e-05	0.000953	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CALCA—thyroid cancer	9.58e-05	0.000952	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.56e-05	0.000949	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CHST14—thyroid cancer	9.55e-05	0.000949	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—NRAS—thyroid cancer	9.45e-05	0.000939	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—NRAS—thyroid cancer	9.45e-05	0.000939	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	9.34e-05	0.000928	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.21e-05	0.000915	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TRIM33—thyroid cancer	9.06e-05	0.000899	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TSHR—thyroid cancer	8.96e-05	0.00089	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PRKAR1A—thyroid cancer	8.82e-05	0.000876	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDK1—thyroid cancer	8.67e-05	0.000861	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NDUFA13—thyroid cancer	8.51e-05	0.000845	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MEN1—thyroid cancer	8.43e-05	0.000837	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	8.26e-05	0.000821	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—thyroid cancer	8.13e-05	0.000808	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—thyroid cancer	8.13e-05	0.000808	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HPGD—thyroid cancer	8.12e-05	0.000807	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC5A5—thyroid cancer	8.06e-05	0.0008	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	8.04e-05	0.000798	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC5A5—thyroid cancer	8.02e-05	0.000797	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CHST14—thyroid cancer	8e-05	0.000795	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.74e-05	0.000769	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTCH1—thyroid cancer	7.62e-05	0.000757	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.55e-05	0.00075	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.52e-05	0.000747	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SST—thyroid cancer	6.97e-05	0.000692	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRG1—thyroid cancer	6.96e-05	0.000691	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—thyroid cancer	6.91e-05	0.000687	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—thyroid cancer	6.91e-05	0.000687	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	6.83e-05	0.000679	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—RXRA—thyroid cancer	6.77e-05	0.000672	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—RXRA—thyroid cancer	6.74e-05	0.00067	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CALCA—thyroid cancer	6.71e-05	0.000666	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.59e-05	0.000654	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.58e-05	0.000654	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.56e-05	0.000651	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HPGD—thyroid cancer	6.45e-05	0.00064	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TERT—thyroid cancer	6.25e-05	0.000621	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—AKT1—thyroid cancer	6.1e-05	0.000606	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—AKT1—thyroid cancer	6.1e-05	0.000606	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDK1—thyroid cancer	6.07e-05	0.000603	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TCF7L1—thyroid cancer	6.04e-05	0.0006	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HIF1A—thyroid cancer	5.98e-05	0.000594	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.62e-05	0.000558	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	5.44e-05	0.000541	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.43e-05	0.000539	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.23e-05	0.000519	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—BRAF—thyroid cancer	4.95e-05	0.000492	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRG1—thyroid cancer	4.88e-05	0.000484	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TPR—thyroid cancer	4.67e-05	0.000463	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.59e-05	0.000456	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TPR—thyroid cancer	4.42e-05	0.000439	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—thyroid cancer	4.38e-05	0.000435	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKAR1A—thyroid cancer	4.35e-05	0.000432	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARG—thyroid cancer	4.27e-05	0.000424	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARG—thyroid cancer	4.26e-05	0.000423	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HIF1A—thyroid cancer	4.19e-05	0.000416	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.17e-05	0.000414	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.16e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MEN1—thyroid cancer	4.16e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—thyroid cancer	4e-05	0.000397	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TPR—thyroid cancer	3.7e-05	0.000368	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.7e-05	0.000368	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PRKAR1A—thyroid cancer	3.64e-05	0.000362	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.49e-05	0.000347	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—thyroid cancer	3.49e-05	0.000346	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—thyroid cancer	3.47e-05	0.000344	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—thyroid cancer	3.36e-05	0.000334	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—thyroid cancer	3.35e-05	0.000333	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALCA—thyroid cancer	3.31e-05	0.000329	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.3e-05	0.000328	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.27e-05	0.000325	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.13e-05	0.000311	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—thyroid cancer	3.11e-05	0.000309	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDK1—thyroid cancer	3e-05	0.000298	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—RXRA—thyroid cancer	2.93e-05	0.000291	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—thyroid cancer	2.93e-05	0.000291	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—thyroid cancer	2.92e-05	0.00029	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.85e-05	0.000283	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—thyroid cancer	2.77e-05	0.000275	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—thyroid cancer	2.68e-05	0.000266	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—thyroid cancer	2.53e-05	0.000251	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—thyroid cancer	2.44e-05	0.000243	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRG1—thyroid cancer	2.41e-05	0.000239	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—RXRA—thyroid cancer	2.33e-05	0.000231	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—thyroid cancer	2.28e-05	0.000226	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.27e-05	0.000225	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—thyroid cancer	2.18e-05	0.000216	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—thyroid cancer	2.16e-05	0.000214	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HIF1A—thyroid cancer	2.07e-05	0.000205	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—thyroid cancer	2.01e-05	0.0002	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—thyroid cancer	1.88e-05	0.000186	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARG—thyroid cancer	1.85e-05	0.000184	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—thyroid cancer	1.71e-05	0.00017	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—thyroid cancer	1.69e-05	0.000168	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—thyroid cancer	1.68e-05	0.000167	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—thyroid cancer	1.67e-05	0.000166	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—thyroid cancer	1.59e-05	0.000158	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000146	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—thyroid cancer	1.46e-05	0.000145	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—thyroid cancer	1.41e-05	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—thyroid cancer	1.27e-05	0.000126	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—thyroid cancer	1.2e-05	0.00012	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—thyroid cancer	1.08e-05	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—thyroid cancer	1.01e-05	0.0001	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—thyroid cancer	9.25e-06	9.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—thyroid cancer	7.86e-06	7.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—thyroid cancer	7.33e-06	7.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—thyroid cancer	6.94e-06	6.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—thyroid cancer	5.82e-06	5.78e-05	CbGpPWpGaD
